In some cancer cell contexts, effects of Gmnn inhibition have been shown to be independent of the mutational status of the tumor suppressor TP53, with Gmnn loss inducing accumulation of excess genomic DNA, G2/M checkpoint activation, and apoptosis in both TP53+ and TP53-cells [10, 78, 79]. The gene discussed is GMNN; the disease is cancer.